Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Expression of the Chondroitin Sulphate Proteoglycan, NG2, in Paediatric Brain Tumors

SAMANTHA C. HIGGINS, ANNA J. BOLTEUS, LAURA K. DONOVAN, HARUTOMO HASEGAWA, LAWRENCE DOEY, SAFA AL SARRAJ, ANDREW KING, KEYOUMARS ASHKAN, FEDERICO RONCAROLI, HELEN L. FILLMORE and GEOFFREY J. PILKINGTON
Anticancer Research December 2014, 34 (12) 6919-6924;
SAMANTHA C. HIGGINS
1Cellular and Molecular Neuro-oncology Group, Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: samantha.higgins{at}port.ac.uk
ANNA J. BOLTEUS
2Experimental Neuro-oncology Group, Department of Neuropathology, Institute of Psychiatry, King's College London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LAURA K. DONOVAN
3Division of Neurosurgery, The Hospital for Sick Kids, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARUTOMO HASEGAWA
4King's College Hospital, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LAWRENCE DOEY
4King's College Hospital, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SAFA AL SARRAJ
4King's College Hospital, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREW KING
4King's College Hospital, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEYOUMARS ASHKAN
4King's College Hospital, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FEDERICO RONCAROLI
5Neuropathology, Department of Medicine, Charing Cross Hospital, Imperial College, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HELEN L. FILLMORE
1Cellular and Molecular Neuro-oncology Group, Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEOFFREY J. PILKINGTON
1Cellular and Molecular Neuro-oncology Group, Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: While neuron-glia 2 (NG2) is well-characterized in the developing brain and in adult high-grade gliomas, little is known about NG2 expression in paediatric brain tumors. Here, NG2 expression was examined in a range of paediatric brain tumors. Materials and Methods: A retrospective immunohistopathological analysis of 57 paediatric brain tumor biopsies of various tumor types was carried out. Paediatric cell lines, including two medulloblastomas and one dysembryoplastic neuroepithelial tumor, in addition to one adult high-grade glioma, were also assessed for NG2 expression. Results: NG2-positive staining was seen in all dysembryoplastic neuroepithelial tumors (DNETs) examined; however, only two of the fourteen medulloblastomas examined were NG2-positive. Compared to adult glioma, there was a lack of NG2 staining in the vasculature of paediatric brain tumors. Conclusion: NG2 expression in paediatric brain tumors differs depending upon type and, unlike adult glioma, includes expression on lower-grade tumors.

  • Brain tumors
  • NG2
  • paediatric
  • Received August 12, 2014.
  • Revision received September 16, 2014.
  • Accepted September 23, 2014.
  • Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
View Full Text
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 34, Issue 12
December 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Expression of the Chondroitin Sulphate Proteoglycan, NG2, in Paediatric Brain Tumors
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Expression of the Chondroitin Sulphate Proteoglycan, NG2, in Paediatric Brain Tumors
SAMANTHA C. HIGGINS, ANNA J. BOLTEUS, LAURA K. DONOVAN, HARUTOMO HASEGAWA, LAWRENCE DOEY, SAFA AL SARRAJ, ANDREW KING, KEYOUMARS ASHKAN, FEDERICO RONCAROLI, HELEN L. FILLMORE, GEOFFREY J. PILKINGTON
Anticancer Research Dec 2014, 34 (12) 6919-6924;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Expression of the Chondroitin Sulphate Proteoglycan, NG2, in Paediatric Brain Tumors
SAMANTHA C. HIGGINS, ANNA J. BOLTEUS, LAURA K. DONOVAN, HARUTOMO HASEGAWA, LAWRENCE DOEY, SAFA AL SARRAJ, ANDREW KING, KEYOUMARS ASHKAN, FEDERICO RONCAROLI, HELEN L. FILLMORE, GEOFFREY J. PILKINGTON
Anticancer Research Dec 2014, 34 (12) 6919-6924;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal Fibroblasts
  • Contribution of Xeroderma Pigmentosum Complementation Group C Genotypes to Colorectal Cancer in Taiwanese
  • Phenotypic Alteration and Suppression of Cytotoxicity of Decidual NK Cells After Co-culturing With Different Trophoblastic Cell Lines
Show more Experimental Studies

Similar Articles

Keywords

  • Brain tumors
  • NG2
  • paediatric
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire